Literature DB >> 5101779

Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

E H Vallota, J Forristal, R E Spitzer, N C Davis, C D West.   

Abstract

Serum levels of complement components and of C3 nephritic factor (C3NeF) were measured serially in two patients with membrano-proliferative glomerulonephritis who were subjected to bilateral nephrectomy and maintained by peritoneal dialysis for 2 wk before renal transplantation. In both patients, low levels of C3 and high levels of preformed alpha 2D, a C3 breakdown product, were present before nephrectomy and remained essentially unchanged during the anephric period. With transplantation, C3 levels rose towards normal and alpha 2D disappeared from the serum. The serum of both patients contained detectable amounts of C3NeF, a factor which has been shown to react with a cofactor found in normal serum to form an enzyme, designated C3 lytic nephritic factor (C3LyNeF), which will cleave C3 to form the breakdown products, beta1A and alpha 2D. The level of C3NeF was high in one patient before nephrectomy, increased somewhat during the anephric period, and fell after transplantation. In the other patient, the C3NeF level was initially lower, remained relatively constant during the anephric period, and was not significantly affected by transplantation. In both patients, levels of C4 and C5 were either normal or elevated over the period of the study and bore no relationship to the C3 level. The following conclusions can be drawn from the data. The high levels of alpha 2D during the anephric period and the disappearance of this protein as C3 levels approach normal at the time of transplantation indicate that the low C3 levels were largely the result of C3 breakdown rather than diminished synthesis. The presence of C3NeF in detectable amounts in both patients suggest that C3LyNeF, formed by the reaction of C3NeF and cofactor, was responsible for the low C3 levels. Finally, the lack of effect of nephrectomy on C3, alpha 2D, and C3NeF levels indicate that the site of C3 breakdown was extrarenal and that C3NeF and cofactor are at least in large part of extrarenal origin.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5101779      PMCID: PMC291962          DOI: 10.1172/JCI106524

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

Authors:  C D WEST; J D NORTHWAY; N C DAVIS
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

Review 2.  IMMUNOLOGIC BASIS OF RENAL DISEASE.

Authors:  A F MICHAEL; K N DRUMMOND; R L VERNIER; R A GOOD
Journal:  Pediatr Clin North Am       Date:  1964-08       Impact factor: 3.278

3.  Serum complement in acute glomerulonephritis and other renal diseases.

Authors:  E E FISCHEL; D C GAJDUSEK
Journal:  Am J Med       Date:  1952-02       Impact factor: 4.965

4.  Acute poststreptococcal glomerulonephritis: immune deposit disease.

Authors:  A F Michael; K N Drummond; R A Good; R L Vernier
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

5.  Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei.

Authors:  T Tojo; G J Friou
Journal:  Science       Date:  1968-08-30       Impact factor: 47.728

6.  Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.

Authors:  C D West; S Winter; J Forristal; J M McConville; N C Davis
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

7.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

8.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

9.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  C G COCHRANE; E R UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

View more
  13 in total

Review 1.  C3 glomerulopathy: a new classification.

Authors:  Fadi Fakhouri; Véronique Frémeaux-Bacchi; Laure-Hélène Noël; H Terence Cook; Matthew C Pickering
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

Review 2.  Complement and the kidney.

Authors:  D K Peters; D G Williams
Journal:  Proc R Soc Med       Date:  1972-12

Review 3.  The immunological basis of glomerulonephritis.

Authors:  D K Peters
Journal:  Proc R Soc Med       Date:  1974-06

4.  Hypocomplementaemic membranoproliferative glomerulonephritis and nephrotic syndrome associated with partial lipodystrophy of the face and trunk.

Authors:  D G Williams; J W Scopes; D K Peters
Journal:  Proc R Soc Med       Date:  1972-07

5.  Basement membrane-changes in membranoproliferative glomerulonephritis: a light and electron microscopic study.

Authors:  D Anders; W Thoenes
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-12-31

Review 6.  All Things Complement.

Authors:  Joshua M Thurman; Carla M Nester
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

7.  Persistent glomerulonephritis following the haemolytic-uremic syndrome. Immunopathological and morphological studies.

Authors:  P M Cossio; R P Laguens; D J Pantin; M M de Bracco; F Molinas; L E Voyer; R M Arana
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

8.  Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.

Authors:  E J Ruley; J Forristal; N C Davis; C Andres; C D West
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

9.  Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.

Authors:  Clark D West; John J Bissler
Journal:  Pediatr Nephrol       Date:  2008-07-02       Impact factor: 3.714

Review 10.  Complement components and their autoantibodies.

Authors:  P Norsworthy; K A Davies
Journal:  Mol Biotechnol       Date:  2003-03       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.